News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lineagen, Inc. to Showcase $15 Million Series 'B' Round at the 9th Annual Biotechnology Industry Organization (BIO) Investor Forum


10/4/2010 12:06:44 PM

SALT LAKE CITY--(BUSINESS WIRE)--Lineagen, Inc. (www.lineagen.com), a specialty diagnostics firm offering high-value genetic testing and consultative healthcare services for Autism Spectrum Disorders (ASD), today announced that Dr. Michael S. Paul, President and Chief Executive Officer, will present details of the company’s $15 Million Series ‘B’ investment round at the 9th Annual BIO Investor Forum. Dr. Paul will present at 4:00 p.m. Pacific Time, on Tuesday, October 5th in the Marina Room of the Palace Hotel in San Francisco, CA.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES